Torren Management’s Tandem Diabetes Care TNDM Stock Holding History

Torren Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-379	Closed	-$8.33K	–	1419
2025 Q4	$8.33K	Buy	+379	New	+$6.84K	﹤0.01%	811

Other funds holding TNDM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Torren Management's TNDM Position: Q1 2026 in Review

Torren Management sold out of Tandem Diabetes Care (TNDM) in Q1 2026, closing a stake of 379 shares — an estimated $8.33K sold.

Torren Management first reported a position in TNDM in Q4 2025 and held it in 1 quarter. The position peaked at $8.33K in Q4 2025. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

Torren Management reported no remaining Tandem Diabetes Care position as of Q1 2026 after selling out during the quarter.
Torren Management sold 379 Tandem Diabetes Care shares in Q1 2026, an estimated $8.33K.
Torren Management first reported a position in Tandem Diabetes Care in Q4 2025 and held it in 1 quarter.
Torren Management's Tandem Diabetes Care position peaked at $8.33K in Q4 2025.
272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on Torren Management's 13F filing for Q1 2026, filed 30 Apr 2026.